Cargando…
PF‐07059013: A non‐covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell disease
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360071/ https://www.ncbi.nlm.nih.gov/pubmed/33891711 http://dx.doi.org/10.1002/ajh.26204 |
| _version_ | 1783737669928353792 |
|---|---|
| author | Knee, Kelly M. Jasuja, Reema Barakat, Amey Rao, Dharani Wenzel, Zane Jasti, Jayasankar Novak, Jonathan Beaumont, Kevin Piotrowski, David W. Jeffrey, Phil Bulawa, Christine Murphy, John E. Janz, Jay M. |
| author_facet | Knee, Kelly M. Jasuja, Reema Barakat, Amey Rao, Dharani Wenzel, Zane Jasti, Jayasankar Novak, Jonathan Beaumont, Kevin Piotrowski, David W. Jeffrey, Phil Bulawa, Christine Murphy, John E. Janz, Jay M. |
| author_sort | Knee, Kelly M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8360071 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley & Sons, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83600712021-08-17 PF‐07059013: A non‐covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell disease Knee, Kelly M. Jasuja, Reema Barakat, Amey Rao, Dharani Wenzel, Zane Jasti, Jayasankar Novak, Jonathan Beaumont, Kevin Piotrowski, David W. Jeffrey, Phil Bulawa, Christine Murphy, John E. Janz, Jay M. Am J Hematol Correspondence John Wiley & Sons, Inc. 2021-05-13 2021-08-01 /pmc/articles/PMC8360071/ /pubmed/33891711 http://dx.doi.org/10.1002/ajh.26204 Text en © 2021 Pfizer Inc. American Journal of Hematology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Correspondence Knee, Kelly M. Jasuja, Reema Barakat, Amey Rao, Dharani Wenzel, Zane Jasti, Jayasankar Novak, Jonathan Beaumont, Kevin Piotrowski, David W. Jeffrey, Phil Bulawa, Christine Murphy, John E. Janz, Jay M. PF‐07059013: A non‐covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell disease |
| title | PF‐07059013: A non‐covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell disease |
| title_full | PF‐07059013: A non‐covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell disease |
| title_fullStr | PF‐07059013: A non‐covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell disease |
| title_full_unstemmed | PF‐07059013: A non‐covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell disease |
| title_short | PF‐07059013: A non‐covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell disease |
| title_sort | pf‐07059013: a non‐covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell disease |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360071/ https://www.ncbi.nlm.nih.gov/pubmed/33891711 http://dx.doi.org/10.1002/ajh.26204 |
| work_keys_str_mv | AT kneekellym pf07059013anoncovalenthemoglobinmodulatorfavorablyimpactsdiseasestateinamousemodelofsicklecelldisease AT jasujareema pf07059013anoncovalenthemoglobinmodulatorfavorablyimpactsdiseasestateinamousemodelofsicklecelldisease AT barakatamey pf07059013anoncovalenthemoglobinmodulatorfavorablyimpactsdiseasestateinamousemodelofsicklecelldisease AT raodharani pf07059013anoncovalenthemoglobinmodulatorfavorablyimpactsdiseasestateinamousemodelofsicklecelldisease AT wenzelzane pf07059013anoncovalenthemoglobinmodulatorfavorablyimpactsdiseasestateinamousemodelofsicklecelldisease AT jastijayasankar pf07059013anoncovalenthemoglobinmodulatorfavorablyimpactsdiseasestateinamousemodelofsicklecelldisease AT novakjonathan pf07059013anoncovalenthemoglobinmodulatorfavorablyimpactsdiseasestateinamousemodelofsicklecelldisease AT beaumontkevin pf07059013anoncovalenthemoglobinmodulatorfavorablyimpactsdiseasestateinamousemodelofsicklecelldisease AT piotrowskidavidw pf07059013anoncovalenthemoglobinmodulatorfavorablyimpactsdiseasestateinamousemodelofsicklecelldisease AT jeffreyphil pf07059013anoncovalenthemoglobinmodulatorfavorablyimpactsdiseasestateinamousemodelofsicklecelldisease AT bulawachristine pf07059013anoncovalenthemoglobinmodulatorfavorablyimpactsdiseasestateinamousemodelofsicklecelldisease AT murphyjohne pf07059013anoncovalenthemoglobinmodulatorfavorablyimpactsdiseasestateinamousemodelofsicklecelldisease AT janzjaym pf07059013anoncovalenthemoglobinmodulatorfavorablyimpactsdiseasestateinamousemodelofsicklecelldisease |